Investigational Site Number :3800003

Brescia 25123

0 studies enrolling now · 2 studies all time

What they study most

Plasma Cell Myeloma, Squamous Cell Carcinoma of Head and Neck

Studies at this site

• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204) — Stopped early
• Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients — Completed